By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Therapeutics, Inc. Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/14/2016 11:06:22 AM
Capricor Therapeutics, Inc. Announces Plans To Expand Clinical Development Program In Duchenne Muscular Dystrophy To Evaluate Peripheral And Respiratory Muscle Function 11/11/2016 11:11:25 AM
Capricor Therapeutics, Inc. To Hold Third Quarter 2016 Business Update And Financial Results Conference Call And Webcast On Thursday, November 10 At 5:00 P.M. ET 11/3/2016 10:51:24 AM
Capricor Therapeutics, Inc. Presents Positive 12-Month Results From DYNAMIC At TCT 2016 10/31/2016 7:29:29 AM
Capricor Therapeutics, Inc. Awarded Up To $4.2 Million From NIH To Evaluate Exosomes For Hypoplastic Left Heart Syndrome 10/20/2016 8:25:50 AM
Capricor Therapeutics, Inc. Completes Enrollment In Phase II ALLSTAR Clinical Trial 10/5/2016 6:39:08 AM
Capricor Therapeutics, Inc. To Present At Upcoming Investor Conferences 9/29/2016 11:13:52 AM
Capricor Therapeutics, Inc. Awarded $2.4 Million From U.S. Department Of Defense To Support Manufacturing Process Development For Therapeutic Exosomes 9/26/2016 8:12:05 AM
Capricor Therapeutics, Inc. Announces Closing Of Public Offerings Raising Approximately $10.0 Million In Net Proceeds 9/21/2016 10:33:04 AM
Capricor Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock 9/16/2016 6:41:37 AM
123456789
//-->